Autopsy report · NCT01013701

Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease

“Terminated based on mutual agreement between PI and sponsor (Glaxo Smith Kline)”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 8 months before it stopped.
• 7 participants enrolled.
• Results were posted on the registry 7 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Patients With Nasal Polyps

Interventions

fluticasone furoate; placebo

Participants

7

Trials that died the same way

• RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
  “Terminated by mutual agreement by sponsor and institution.” (74% match in meaning)
• Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
  “Terminated by previous Sponsor decision” (70% match in meaning)
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
  “Terminated by sponsor” (69% match in meaning)
• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
  “Terminated - Sponsor Decision” (68% match in meaning)
• Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis
  “Sponsor requested termination” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.